DE3773387D1 - Kombination von gammainterferonen und antientzuendungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten. - Google Patents

Kombination von gammainterferonen und antientzuendungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten.

Info

Publication number
DE3773387D1
DE3773387D1 DE8787903945T DE3773387T DE3773387D1 DE 3773387 D1 DE3773387 D1 DE 3773387D1 DE 8787903945 T DE8787903945 T DE 8787903945T DE 3773387 T DE3773387 T DE 3773387T DE 3773387 D1 DE3773387 D1 DE 3773387D1
Authority
DE
Germany
Prior art keywords
diseases
agents
treatment
combination
gamma interferon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE8787903945T
Other languages
English (en)
Inventor
Steven D Reich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen Inc
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25365733&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3773387(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogen Inc filed Critical Biogen Inc
Application granted granted Critical
Publication of DE3773387D1 publication Critical patent/DE3773387D1/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8787903945T 1986-06-17 1987-06-01 Kombination von gammainterferonen und antientzuendungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten. Revoked DE3773387D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87540186A 1986-06-17 1986-06-17
PCT/US1987/001228 WO1987007842A1 (en) 1986-06-17 1987-06-01 Combinations of gamma interferons and anti-inflammatory or anti-pyretic agents and methods for treating diseases

Publications (1)

Publication Number Publication Date
DE3773387D1 true DE3773387D1 (de) 1991-10-31

Family

ID=25365733

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787903945T Revoked DE3773387D1 (de) 1986-06-17 1987-06-01 Kombination von gammainterferonen und antientzuendungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten.

Country Status (5)

Country Link
EP (1) EP0311616B1 (de)
JP (1) JPH01502980A (de)
AT (1) ATE67675T1 (de)
DE (1) DE3773387D1 (de)
WO (1) WO1987007842A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200177A (en) * 1989-12-01 1993-04-06 The Children's Medical Center Corporation Treatment of atopic disorders with gamma-interferon
EP0502997B1 (de) * 1989-12-01 1995-05-03 Children's Medical Center Corporation Verwendung von Gamma-Interferon zur Herstellung eines Medikaments für die Behandlung von Steroid-abhängigem Asthma
DE69229880T2 (de) * 1991-11-19 2000-05-04 The University Of Virginia Patent Foundation, Charlottesville Kombinierte virustatikum-antimediator-behandlung (covam) von gewöhnlichen erkältungen
US5266312A (en) * 1992-01-07 1993-11-30 National Jewis Center For Immunology And Respiratory Medicine Method for treating a steroid resistant condition via administration of gamma interferon
GB2293323A (en) * 1994-09-12 1996-03-27 Orion Yhtymae Oy Antibiotics and bismuth salts for treating bacterial infections
ES2190788T3 (es) * 1994-09-16 2003-08-16 Harvard College Utilizacion de halogenuros aromaticos para tratar la proliferacion de celulas mamarias.
KR980700872A (ko) * 1994-12-28 1998-04-30 야마구찌 다까시 경점막 투여용 제제(transmucosal preparation)
GB2304342A (en) * 1995-08-18 1997-03-19 Univ Manchester Pharmaceutical comprising either an inhibitor or a stimulator of interferon gamma
EP0795332B1 (de) * 1996-03-14 2005-06-01 Mondobiotech Interferon SA Medizinische Verwendung von Gamma-Interferon im interstitiellen Lungenerkrankungen
US6299871B1 (en) * 1998-07-24 2001-10-09 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Orally-administrable therapeutic and/or prophylactic agent for HTLV-1-related diseases
CA2387089A1 (en) * 1999-11-10 2001-05-17 Mondobiotech Sa Interferon gamma for the treatment of asthma
GB0518558D0 (en) 2005-09-12 2005-10-19 Givaudan Sa Improvements in or related to organic compounds
FR2958849A1 (fr) * 2010-04-14 2011-10-21 Boiron Medicament homeopathique a activite anti-cancereuse

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252797A (en) * 1979-07-19 1981-02-24 Walter Rosenthal Corticosteroid calcium compositions and treatment of rheumatic diseases therewith
US4246263A (en) * 1979-10-15 1981-01-20 Pfizer Inc. Antiinflammatory and immunoregulatory pyrimidines, their method of use and pharmaceutical compositions
US4390545A (en) * 1981-11-19 1983-06-28 American Cyanamid Company Combinations of agents which give enhanced anti-inflammatory activity
EP0177342A3 (de) * 1984-10-04 1987-12-02 Genentech, Inc. Orale Formulierungen therapeutischer Proteine
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
DE3436638C2 (de) * 1984-10-05 1992-10-08 Bioferon biochemische Substanzen GmbH & Co, 7958 Laupheim Verwendung von Interferon-gamma (IFN-gamma) enthaltenden Präparationen zur Behandlung rheumatischer Erkrankungen

Also Published As

Publication number Publication date
EP0311616A1 (de) 1989-04-19
JPH01502980A (ja) 1989-10-12
EP0311616B1 (de) 1991-09-25
ATE67675T1 (de) 1991-10-15
EP0311616A4 (de) 1989-05-23
WO1987007842A1 (en) 1987-12-30

Similar Documents

Publication Publication Date Title
ATE126441T1 (de) Pentigetide zur behandlung von nicht-ige- vermittelten entzündlichen erkrankungen.
DE3773387D1 (de) Kombination von gammainterferonen und antientzuendungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten.
ATE277612T1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
DE3579113D1 (de) Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
DE69229050D1 (de) Verwendung von Papillomavirusprotein L2 zur therapeutischen Behandlung von durch Papillomavirus hervorgerufenen Tumoren oder oder anderen krankhaften Veränderungen
DE69703689D1 (de) Therapeutische anwendungen von bpi-protein-produkten zur behandlung von humaner meningococcämia
DE69200685D1 (de) Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3-Benzazepin-2-ones, verwendbar in der Behandlung von kardiovaskularen Krankheiten.
NO844579L (no) Enzymresistente immunomodulerende peptider.
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
DE69434223D1 (de) In der behandlung von il4 auslösenden krankheiten nützliche rekombinante il4 antikörper
DK467487A (da) Polypeptid, anvendeligt til lindring, behandling og diagnosticering af autoimmunitetssygdomme, isaer arthritis
DE68921979D1 (de) Antikörper für die antilymphozyten-antikörpertherapie.
DK0610286T3 (da) Rekombinante immunotoxiner
ATE174219T1 (de) Verwendung von leflunomid zur hemmung von tumornekrosefaktor alpha
NO964238L (no) Halofantrin-fri-base for behandling av malaria og blandinger
DE69429101D1 (de) Verbindungen und zusammensetzungen zur behandlung von allergien und entzündungen
ATE17480T1 (de) Entzuendungshemmende und/oder schmerzstillende 2,3-diaryl-5-halo thiophene.
DE3679781D1 (de) Verwendung von zusammensetzungen fuer die behandlung und die prophylaxe von epithelialer zerstoerung.
ATE86492T1 (de) Anwendung von sterolinen und spiroketalinen zur herstellung von medikamenten zur behandlung von psoriasis.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
DE69418931D1 (de) Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten
DE3863200D1 (de) In der krebstherapie verwendbare zusammensetzung auf der basis von aminosaeure und vitaminen.
DE3674619D1 (de) Zusammensetzung fuer baeder auf basis von psoralen in der behandlung von psoriasis.
GR80629B (en) Pharmacologically active diarylindane -1,3-diones
ATE238795T1 (de) Verwendung von aminothiazolen zur wund- und hautbehandlung

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation